ClassID:

93209

C07C275/16 - CPC Classification

Classification description:

Derivatives of urea, i.e. compounds containing any of the groups , the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by carboxyl groups

Recent Application in this class:
#1
20260132139
2026-05-14

HIV INHIBITOR COMPOUNDS

#2
20260091008
2026-04-02

DOUBLE TARGETED CONSTRUCTS TO AFFECT TUMOR KILL

#3
20250177578
2025-06-05

PSMA-BINDING AGENTS AND USES THEREOF

#4
20250171406
2025-05-29

AMINO ACID COMPOSITIONS

#5
20250163001
2025-05-22

AMINO ACID COMPOSITIONS

#6
20250163000
2025-05-22

AMINO ACID COMPOSITIONS

#7
20250162999
2025-05-22

AMINO ACID COMPOSITIONS

#8
20250162998
2025-05-22

AMINO ACID COMPOSITIONS

#9
20250162997
2025-05-22

AMINO ACID COMPOSITIONS

#10
20250162996
2025-05-22

AMINO ACID COMPOSITIONS

#11
20250049948
2025-02-13

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

#12
20250042910
2025-02-06

HIV INHIBITOR COMPOUNDS

#13
20240391870
2024-11-28

IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY

#14
20240284937
2024-08-29

APPLICATION OF ASPARTIC ACID DERIVATIVE IN PREPARING ANIMAL FEED ADDITIVE

#15
20230414794
2023-12-28

PSMA INHIBITOR, COMPOUND AND APPLICATION

#16
20230295081
2023-09-21

IONIZABLE CATIONIC LIPIDS FOR RNA DELIVERY

#17
20230257343
2023-08-17

NOVEL AMINO ACID DERIVATIVES

#18
20230097871
2023-03-30

UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR

#19
20230095637
2023-03-30

Heterodimers of Glutamic Acid

#20
20230027055
2023-01-26

HIV inhibitor compounds

#21
20230019098
2023-01-19

BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF

#22
20220396621
2022-12-15

TARGETING AGENT ANTIBODY CONJUGATES AND USES THEREOF

#23
20220194904
2022-06-23

18F-LABELED TRIAZOLE CONTAINING PSMA INHIBITORS

#24
20220088229
2022-03-24

PSMA-binding agents and uses thereof

#25
20220015393
2022-01-20

Application of aspartic acid derivative in preparing animal feed additive

#26
20210323985
2021-10-21

SHIELDING AGENTS AND THEIR USE

#27
20210246103
2021-08-12

HETERODIMERS OF GLUTAMIC ACID

#28
20210137860
2021-05-13

Double targeted constructs to affect tumor kill

#29
20210070696
2021-03-11

HETERODIMERS OF GLUTAMIC ACID

#30
20210070695
2021-03-11

HETERODIMERS OF GLUTAMIC ACID

#31
20200407471
2020-12-31

Carbamate functional monomers and polymers and use thereof

#32
20200360542
2020-11-19

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

#33
20200297678
2020-09-24

Amino acid compositions

#34
20200282083
2020-09-10

PSMA-BINDING AGENTS AND USES THEREOF

#35
20200170960
2020-06-04

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER

#36
20190315863
2019-10-17

Targeting agent antibody conjugates and uses thereof

#37
20190315701
2019-10-17

Eicosanoid derivatives

#38
20190308983
2019-10-10

HIV inhibitor compounds

#39
20190276393
2019-09-12

Heterodimers of glutamic acid

#40
20190270770
2019-09-05

DIPEPTIDYL KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF FAT ACCUMULATION

#41
20190223814
2019-07-25

18F labeled amino acids, derivatives thereof and method of making same

#42
20190142770
2019-05-16

Double targeted constructs to affect tumor kill

#43
20180258097
2018-09-13

HIV inhibitor compounds

#44
20180244718
2018-08-30

Foldamer helix bundle-based molecular encapsulation

#45
20180237473
2018-08-23

Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation

#46
20180236110
2018-08-23

PSMA-binding agents and uses thereof

#47
20180118661
2018-05-03

Compounds and methods for the treatment of neurodegenerative diseases

#48
20180111895
2018-04-26

Heterodimers of glutamic acid

#49
20170368005
2017-12-28

Double targeted constructs to affect tumor kill

#50
20170333576
2017-11-23

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

#51
20170267717
2017-09-21

Method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer

#52
20170246327
2017-08-31

18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer

#53
20170135961
2017-05-18

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

#54
20170044288
2017-02-16

CARBAMATE, THIOCARBAMATE OR CARBAMIDE COMPRISING A BIOMOLECULAR MOIETY

#55
20170044098
2017-02-16

Heterodimers of glutamic acid

#56
20160367481
2016-12-22

Cancer cell targeting using nanoparticles

#57
20160326128
2016-11-10

Eicosanoid derivatives

#58
20160279235
2016-09-29

Heterodimers of glutamic acid

#59
20160237212
2016-08-18

Methods for post-fabrication functionalization of poly(ester ureas)

#60
20160176811
2016-06-23

Amino acid derivatives

#61
20160115232
2016-04-28

Targeting agent antibody conjugates and uses thereof

#62
20160114060
2016-04-28

PSMA-binding agents and uses thereof

#63
20150203517
2015-07-23

Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs

#64
20150174089
2015-06-25

Substituted aminobutyric derivatives as neprilysin inhibitors

#65
20150125898
2015-05-07

COMPOSITIONS AND KITS FOR DIAGNOSING INFECTIONS

#66
20140369931
2014-12-18

PSMA-binding agents and uses thereof

#67
20140235706
2014-08-21

Cancer cell targeting using nanoparticles

#68
20140212916
2014-07-31

Method for diagnosing infection

#69
20140179902
2014-06-26

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

#70
20140147403
2014-05-29

Glutamine derivatives as deodorants

#71
20130237580
2013-09-12

Peptidomimetic compounds as immunomodulators

#72
20120296116
2012-11-22

Process for the production of L-Citrulline

#73
20120289554
2012-11-15

4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES

#74
20120269726
2012-10-25

Heterodimers of glutamic acid

#75
20120252830
2012-10-04

Substituted aminobutyric derivatives as neprilysin inhibitors

#76
20120208988
2012-08-16

Heterodimers of glutamic acid

#77
20120122972
2012-05-17

Eicosanoid derivatives

#78
20120009840
2012-01-12

Partially fluorinated ureas and amides

#79
20120004293
2012-01-05

Cancer cell targeting using nanoparticles

#80
20110313043
2011-12-22

Amino acid compositions

#81
20110224288
2011-09-15

Cancer cell targeting using nanoparticles

#82
20110200677
2011-08-18

Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer

#83
20110172174
2011-07-14

Antibacterial agents

#84
20110142760
2011-06-16

PSMA-binding agents and uses thereof

#85
20110136905
2011-06-09

Crystalline teglicar

#86
20110130350
2011-06-02

Synthesis scheme for lacosamide

#87
20110008253
2011-01-13

Process for production of heterodimers of glutamic acid

#88
20100324025
2010-12-23

Antibacterial agents

#89
20100305145
2010-12-02

Substituted aminobutyric derivatives as neprilysin inhibitors

#90
20100256416
2010-10-07

Process for production of N-carbamoyl-tert-leucine

#91
20100204376
2010-08-12

Rheology control agents

#92
20100183509
2010-07-22

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

#93
20100178246
2010-07-15

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA

#94
20100144825
2010-06-10

Renin inhibitors

#95
20100099786
2010-04-22

Carbamate, thiocarbamate or carbamide comprising a biomolecular moiety

#96
20090312286
2009-12-17

DERIVATIVES OF 4-TRIMETHYLAMMONIUM-3-AMINOBUTYRATE AND 4-TRIMETHYLPHOSPHONIUM-3-AMINOBUTYRATE AS CPT-INHIBITORS

#97
20090270505
2009-10-29

4-dimethylaminobutyric acid derivatives

#98
20090247506
2009-10-01

Antibacterial agents

#99
20090215730
2009-08-27

Antineoplastic compounds and pharmaceutical compositions thereof

#100
20090163496
2009-06-25

Antibacterial agents

#101
20090142813
2009-06-04

Processes for the production of L-citrulline

#102
20090062271
2009-03-05

Antithrombotic diamides

#103
20090061010
2009-03-05

Cancer cell targeting using nanoparticles

#104
20090047498
2009-02-19

METHOD FOR PROVIDING NANOWEB COMPOSITE MATERIAL

#105
20090047435
2009-02-19

Partially fluorinated ureas and amides

#106
20090036311
2009-02-05

Benzoyl-Substituted Alanines

#107
20080269221
2008-10-30

Antibacterial agents

#108
20080247991
2008-10-09

Solution Additives For the Attenuation of Protein Aggregation

#109
20080200542
2008-08-21

Benzoyl-substituted serineamides

#110
20080193381
2008-08-14

Heterodimers of glutamic acid

#111
20080176821
2008-07-24

Ligands for metabotropic glutamate receptors and inhibitors of NAALADase

#112
20080161395
2008-07-03

Derivatives of Aminobutanoic Acid Inhibiting Cpt

#113
20080058333
2008-03-06

CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS

#114
20080027137
2008-01-31

Synthesis scheme for lacosamide

#115
20070244197
2007-10-18

Antibacterial agents

#116
20070208166
2007-09-06

Tao Kinase Modulators And Method Of Use

#117
20060155146
2006-07-13

Rheology control agents

#118
20060154988
2006-07-13

Antibacterial agents

#119
20060074110
2006-04-06

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

#120
20060057194
2006-03-16

Cationic liposomes for gene transfer

#121
20050192347
2005-09-01

Urea and thiourea compounds and compositions for cholesterol management and related uses

#122
20050080121
2005-04-14

Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis

#123
20050054819
2005-03-10

Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors

#124
18745858
2025-10-21

Amino acid compositions

#125
17522680
2025-02-18

Amino acid compositions

#126
17522668
2025-03-04

Amino acid compositions

#127
14065372
2019-11-12

Amino acid supplement formulations